Merganser Biotech develops and commercializes minihepcidin peptides for the treatment of hemoglobinopathie.
Business Model:
Revenue: $0
Employees: 11-50
Address: 19 Paper Mill Rd
City: Newtown Square
State: PA
Zip: 19073
Country: US
Merganser Biotech develops and commercializes minihepcidin peptides for the treatment of hemoglobinopathie.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 2/2015 | Series A | 5 | $28M |
BioAdvance Frazier Healthcare Partners Novartis Venture Fund OUP (Osage University Partners) Sutter Hill Ventures BioAdvance Frazier Healthcare Partners Novartis Venture Fund OUP (Osage University Partners) Sutter Hill Ventures |
12/2012 | Seed Round | 1 | - |
BioAdvance BioAdvance |
1/2014 | Series A | 1 | - |
BioAdvance BioAdvance |
4/2013 | Seed Round | 1 | - |
BioAdvance BioAdvance |
12/2016 | Venture Round | 1 | - |
OUP (Osage University Partners) OUP (Osage University Partners) |
12/2016 | Venture Round | 1 | - |
OUP (Osage University Partners) OUP (Osage University Partners) |
1/2014 | Series A | 1 | - |
BioAdvance BioAdvance |
4/2013 | Seed Round | 1 | - |
BioAdvance BioAdvance |
12/2012 | Seed Round | 1 | - |
BioAdvance BioAdvance |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|